Business Context and Reporting Period
Company: Central Garden & Pet Company
Filing Type: Form 10-K (Annual Report)
Fiscal Year Ended: September 25, 1999
Overview: Central is a national manufacturer, supplier, and merchandiser of lawn, garden, and pet supply products. Operations are divided into three segments: Garden Products (24% of sales), Distribution (63% of sales), and Pet Products (13% of sales). The company operates 43 distribution facilities and 22 manufacturing facilities.
Key Financial Metrics
| Metric | Fiscal 1999 | Fiscal 1998 | Change |
|---|---|---|---|
| Net Sales | $1,535.6 million | $1,294.9 million | +18.6% |
| Gross Profit | $352.8 million | $285.7 million | +23.5% |
| Gross Margin | 23.0% | 22.1% | +0.9 pts |
| Income from Operations | $55.8 million | $65.7 million | -15.1% |
| Net Income | $24.5 million | $33.7 million | -27.3% |
| Diluted EPS | $0.89 | $1.15 | -22.6% |
| Operating Cash Flow | $63.6 million | $30.8 million | +106.5% |
| Total Assets | $955.8 million | $928.7 million | +2.9% |
| Short-term Borrowings | $97.4 million | $8.1 million | +1,102% |
| Long-term Debt | $123.9 million | $125.1 million | -1.0% |
| Shareholders' Equity | $495.7 million | $588.8 million | -15.8% |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased by $240.8 million, driven by $132.7 million from acquisitions (including Norcal Pottery) and $108.1 million from organic growth in existing businesses.
- Profitability Decline: Despite revenue growth, Net Income dropped significantly due to a $7.6 million charge related to the expiration of the Solaris Agreement, increased SG&A expenses (up 38.5%), and higher interest expense (up 59%).
- Debt Increase: Short-term borrowings surged to $97.4 million, primarily to fund a $121.7 million stock repurchase program and the Norcal Pottery acquisition.
- Segment Performance: Garden Products sales grew to $381 million (from $240 million in 1998), while Pet Products sales declined slightly to $236 million.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management anticipates a significant reduction in sales volume for fiscal 2000 due to the expiration of the exclusive Solaris Agreement with Monsanto. Scotts Company has assumed distribution of certain products (Ortho, Roundup, Miracle-Gro), estimated to reduce Central's sales by $200-$250 million and gross profit by $15-$25 million. Management plans to offset this loss through expense reductions and new business growth.
Key Risks and Contingencies
- Solaris Agreement Expiration: Final payments and inventory returns related to the expired agreement with Monsanto remain unresolved and could involve litigation.
- Customer Concentration: Wal*Mart accounted for 25% of total sales; Home Depot accounted for 9%. Loss of these customers would be material.
- Supplier Concentration: 43% of Distribution sales were derived from Solaris products. The shift to Scotts introduces uncertainty regarding future margins and volume.
- Seasonality and Weather: Approximately 64% of sales occur in the first six months of the calendar year; adverse weather can materially impact results.
- Year 2000 Compliance: While systems are compliant, risks remain regarding third-party vendors and infrastructure failures.
Investor Verification Checklist
- Solaris Settlement: Verify the final resolution of payments and inventory returns between Central and Monsanto/Scotts.
- Scotts Relationship: Confirm the actual volume and profitability of the new distribution arrangement with Scotts Company in fiscal 2000.
- Stock Repurchase Impact: Assess the sustainability of the $140.7 million stock buyback program given the reduction in operating income.
- Wal*Mart Dependency: Monitor any changes in purchasing patterns from Wal*Mart, which represents a quarter of total revenue.
- Inventory Levels: Review the $75.9 million in inventory held for return to manufacturers and its impact on working capital.